—
Shoden Ashwagandha: verification pending
We’re confirming the science for this compound before we publish a form ranking. Our team reviews every ranked page against peer-reviewed absorption data — this one is still under review, so we are not showing a score yet.
Check back soon. Rankings are reviewed by Dr. Brennan Commerford, D.C.
References
- Human crossover PK: a 35% withanolide-glycoside ashwagandha extract (Shoden specification) showed substantially higher per-gram withanolide absorption (AUC roughly 118 to 268-fold greater) than 2.5%, 5%, and 10% standardized extracts. PubMed
- A randomized placebo-controlled trial reported that a standardized 35% withanolide-glycoside ashwagandha extract (Shoden) was associated with lower stress and anxiety scores versus placebo. PubMed
- Human crossover PK: a 35% withanolide-glycoside extract was reported as roughly 280-fold more bioavailable per mg than a 2.5% withanolide extract. PubMed
- A randomized placebo-controlled trial reported that a standardized ashwagandha extract (Shoden, 120 mg daily) was associated with improved sleep-quality scores versus placebo. PubMed
- A randomized placebo-controlled trial reported that a standardized ashwagandha extract (Shoden, 240 mg daily) was associated with lower anxiety scores and morning cortisol versus placebo. PubMed
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.